virus del papiloma humano y cáncer: epidemiología y prevención ...
virus del papiloma humano y cáncer: epidemiología y prevención ...
virus del papiloma humano y cáncer: epidemiología y prevención ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Xavier Castellsagué Piqué, Ginesa Albero Abril, Dolors Martí Cardona, Mª Jesús Plà Farnós,<br />
Paz Fernández Ortega, Cinta Belloví Fava, Monica Salinas Masdeu, Montserrat Domínguez Arseda,<br />
Esther Roura Fornells, F. Xavier Bosch José<br />
16. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsague X, Shah KV y<br />
cols. Epidemiologic classification of human papilloma<strong>virus</strong> types associated<br />
with cervical cancer. N Engl J Med. 2003; 348(6): 518-27.<br />
17. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen A, Peto J y cols.<br />
Prevalence of human papilloma<strong>virus</strong> in cervical cancer: a worldwide perspective.<br />
J Natl Cancer Inst. 1995; 87: 796-802.<br />
18. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV<br />
y cols. Human papilloma<strong>virus</strong> is a necessary cause of invasive cervical<br />
cancer worldwide. J Pathol. 1999; 189(1): 12-9.<br />
19. Muñoz N, Bosch FX, Castellsague X, Díaz M, de Sanjosé S, Hammouda<br />
D y cols. Against which human papilloma<strong>virus</strong> types shall we vaccinate<br />
and screen? The international perspective. Int J Cancer. 2004; 111(2): 278-<br />
85.<br />
20. Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P,<br />
Dillner J. Virologic versus cytologic triage of women with equivocal Pap<br />
smears: a meta-analysis of the accuracy to detect high-grade intraepithelial<br />
neoplasia. J Natl Cancer Inst. 2004; 96(4): 280-93.<br />
21. Cox JT, Lörincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ.<br />
Human papilloma <strong>virus</strong> testing by hybrid capture appears to be useful in<br />
triaging women with a cytologic diagnosis of atypical squamous cells of<br />
undetermined significance. Am J Obstet Gynecol. 1995; 172: 946-54.<br />
22. Kaufman RH, Adam E, Icenogle J, Reeves WC. Human papilloma<strong>virus</strong> testing<br />
as triage for atypical squamous cells of undetermined significance<br />
and low-grade squamous intraepithelial lesions: sensitivity, specificity,<br />
and cost-effectiveness. Am J Obstet Gynecol. 1997; 177(4): 930-6.<br />
23. Schiffman M, Hildesheim A, Herrero R, Bratti C. Human Papilloma<strong>virus</strong><br />
Testing as a Screening Tool for Cervical Cancer. J Am Med Assoc. 2000;<br />
283(19): 2525-6.<br />
24. Bernard HU. Established and potential strategies against papilloma<strong>virus</strong><br />
infections. J Antimicrob Chemother. 2004; 53(2): 137-9.<br />
25. Zhou J, Sun XY, Stenzel DJ, Frazer IH. Expression of vaccinia recombinant<br />
HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly<br />
of HPV virion-like particles. Virology. 1991; 185(1) 251-7.<br />
26. Kirnbauer R, Chandrachud LM, O’Neil BW, Wagner ER, Grindlay GJ,<br />
Armstrong A y cols. Virus-like particles of bovine papilloma<strong>virus</strong> type 4 in<br />
prophylactic and therapeutic immunization. Virology. 1996; 219(1): 37-44.<br />
27. Schiller JT, Lowy DR. Papilloma<strong>virus</strong>-like particles and HPV vaccine<br />
development. Semin Cancer Biol. 1996; 7(6): 373-82.<br />
28. Zhang LF, Zhou J, Chen S, Cai LL, Bao QY, Zheng FY y cols. HPV6b <strong>virus</strong><br />
like particles are potent immunogens without adjuvant in man. Vaccine.<br />
2000; 18(11-12): 1051-8.<br />
128